PubMed Journals Articles About "Indiana Blood And Marrow Transplantation" RSS

12:56 EDT 18th October 2018 | BioPortfolio

Indiana Blood And Marrow Transplantation PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Indiana Blood And Marrow Transplantation articles that have been published worldwide.

More Information about "Indiana Blood And Marrow Transplantation" on BioPortfolio

We have published hundreds of Indiana Blood And Marrow Transplantation news stories on BioPortfolio along with dozens of Indiana Blood And Marrow Transplantation Clinical Trials and PubMed Articles about Indiana Blood And Marrow Transplantation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Indiana Blood And Marrow Transplantation Companies in our database. You can also find out about relevant Indiana Blood And Marrow Transplantation Drugs and Medications on this site too.

Showing "Indiana Blood Marrow Transplantation" PubMed Articles 1–25 of 11,000+

Teaching a Young Dog New Tricks: Modifications to the Post-Transplantation Cyclophosphamide Haploidentical Transplantation Platform.

Cytomegalovirus infection among cord-blood allogeneic transplantation recipients: low incidence of cytomegalovirus events without high-dose valacyclovir prophylaxis.

Allogeneic hematopoietic cell transplantation following the use of hypomethylating agents among patients with relapsed or refractory AML: Findings from an international retrospective study.

Baseline Renal Function and Albumin are Powerful Predictors for Allogeneic Transplantation-Related Mortality.

Biomarkers measured in blood chemistry before allogeneic hematopoietic stem cell transplantation (HSCT) may reflect patients' physiological status. We hypothesized that selected markers are predictive for non-relapse mortality (NRM) following transplantation and could contribute to risk assessment.

Get Outta' Here! Addition of Mobilizing Agents to Conditioning Regimen Improves Donor Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation for Wiskott-Aldrich Syndrome.

Use of non-cryopreserved peripheral blood stem cells (PBSC) is associated with adequate engraftment in patients with multiple myeloma undergoing an autologous transplant.

Umbilical Cord Blood Expansion: are We There Yet?

Shared Decision-Making in Hematopoietic Stem Cell Transplantation for Sickle Cell Disease.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow allografts have improved Long-term Overall and Graft-versus-Host Disease, Relapse-Free Survival.

Peripheral Blood (PB) or Bone Marrow (BM) from unrelated donors can serve as a graft source for hematopoietic cell transplantation. Currently, PB is most commonly used in roughly 80% of adult recipients. Determining the long-term impact of graft source on outcomes would inform this decision.

KIR genotyping data of more than three million individuals are available for global unrelated stem cell donor searches (Comment to: Weisdorf D, Cooley S, Wang T, et al. KIR donor selection: feasibility in identifying better donors. Biol Blood Marrow Transplant. 2018; doi: 10.1016/j.bbmt.2018.08.022.).

The importance of A, B, Cs! Airways and Breathing matter for survival after HSCT.

Allogeneic HSCT to Cure Transfusion Dependent Thalassemia: Timing Matters!

Primed to Kill: CTV-1 Stimulated Haploidentical Natural Killer Cells for Consolidation of AML.

Turn off the Tap! The Need for Induction Therapy for AL Amyloidosis Before Transplant.

Response to letter to editor for YBBMT-D-18-00212.

Hemorrhagic Cystitis: Brighter Days Ahead.

It's Not All in the Conditioning or the Perils of Early Trial Cessation.

Ten Things to Know About Primary Mediastinal B-cell Lymphoma.

Human herpes virus-6 reactivation and acute graft-versus-host disease.

TBI: To Be (Irradiated) or not to be? That remains the question.

ASBMT Practice Guidelines Committee Survey on Long Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.

Reply to author.

Bone Marrow versus Peripheral Blood from Unrelated Donors for Children and Adolescents with Acute Leukemia.

As graft versus host disease (GVHD) rates are higher after unrelated donor transplantation, we examined whether there would be differences in transplant outcomes by graft type in children and adolescents with acute leukemia. The primary endpoint was overall survival. We studied 872 patients aged less than 18 years transplanted with bone marrow (n = 650) or peripheral blood (n = 222) from unrelated donors. The characteristics of the two groups were comparable except recipients of bone marrow were you...

Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation.

This study aimed to develop a survivorship care plan (SCP) that could be individualized to facilitate long-term follow-up care of hematopoietic cell transplantation (HCT) survivors.


Disease relapse remains an unmet medical need for patients with Hodgkin lymphoma (HL) receiving an allogeneic hematopoietic cell transplantation (HCT).

Quick Search